Orphan drugs in Australia

被引:6
|
作者
Herkes, Geoffrey K. [1 ,2 ,3 ]
机构
[1] Royal North Shore Hosp, Dept Neurol, St Leonards, NSW, Australia
[2] Univ Sydney, Kolling Inst, Med, Sydney, NSW, Australia
[3] Advisory Comm Prescript Med Therapeut Goods Adm, Canberra, ACT, Australia
来源
EXPERT OPINION ON ORPHAN DRUGS | 2016年 / 4卷 / 12期
关键词
Orphan drug program; review; rare diseases; oncology;
D O I
10.1080/21678707.2016.1257383
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1195 / 1197
页数:3
相关论文
共 50 条
  • [11] The Cost of Orphan Drugs: the Swiss Perspective
    Baumgartner, Matthias R.
    PADIATRIE UND PADOLOGIE, 2020, 55 (SUPPL 3): : 72 - 75
  • [12] Analysis of marketed orphan drugs in China
    Zhi, Wei
    Liu, Meilin
    Yang, Dan
    Zhang, Shanshan
    Lu, Yanqin
    Han, Jinxiang
    INTRACTABLE & RARE DISEASES RESEARCH, 2023, 12 (03) : 132 - 140
  • [13] Orphan drugs: The United States experience
    Haffner, ME
    DRUG INFORMATION JOURNAL, 1999, 33 (02): : 565 - 568
  • [14] Orphan drugs: expensive yet necessary
    Hyry, H. I.
    Roos, J. C. P.
    Cox, T. M.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2015, 108 (04) : 269 - 272
  • [15] Patient access to orphan drugs in France
    Bourdoncle, Marion
    Juillard-Condat, Blandine
    Taboulet, Florence
    ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
  • [16] Rare diseases and orphan drugs: Latvian story
    Konstantins Logviss
    Dainis Krievins
    Santa Purvina
    Orphanet Journal of Rare Diseases, 9
  • [17] Rare diseases and orphan drugs: difficulties and perspectives
    Cannizzaro, Emanuele
    Tranchina, Ernesto
    Cannizzaro, Gaspare
    ACTA MEDICA MEDITERRANEA, 2007, 23 (02): : 65 - 68
  • [18] Orphan drugs policies: a suitable case for treatment
    Drummond, Michael
    Towse, Adrian
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (04) : 335 - 340
  • [19] Outrageous prices of orphan drugs: a call for collaboration
    Luzzatto, Lucio
    Hyry, Hanna I.
    Schieppati, Arrigo
    Costa, Enrico
    Simoens, Steven
    Schaefer, Franz
    Roos, Jonathan C. P.
    Merlini, Giampaolo
    Kaariainen, Helena
    Garattini, Silvio
    Hollak, Carla E.
    Remuzzi, Giuseppe
    LANCET, 2018, 392 (10149) : 791 - 794
  • [20] Novel approach to decision making for orphan drugs
    Decker, Barbora
    Mlcoch, Tomas
    Pustovalova, Anastasie
    Dolezal, Tomas
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2023, 39 (01)